Peptide record

TPDB04183

Antibacterial Anticancer Antifungal Antiparasitic Cell-penetrating Peptides Hemolysis Toxicity standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB04183
Antibacterial Anticancer Antifungal Antiparasitic Cell-penetrating Peptides Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb CPPsite3.0 HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 14-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
LLLFLLKKRKKRKY
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C90H159N25O16
ANDCEQGHIMPSTWV
LK
1847.41
11.70
7
0
7
+7
2.15
-0.571
139.29
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
1490
0.81
1
Residue Composition
number
0
A
2
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
5
L
5
K
0
M
1
F
0
P
0
S
0
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 0 R: 2 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 5 K: 5 M: 0 F: 1 P: 0 S: 0 T: 0 W: 0 Y: 1 V: 0
Chemical Descriptors
14 reviewed residue count
C90H159N25O16 sequence-only estimate (linear, free termini)
1847.41 sequence-only estimate (linear, free termini)
11.70 sequence-only estimate (linear, free termini)
+7 sequence-only estimate (linear, free termini)
2.15 sequence-only estimate (linear, free termini)
-0.571 sequence-only estimate (linear, free termini)
Evidence Records 5 records
Evidence 1 Activity

Activity

50% Hemolysis
Toxicity
58±23 µM
Hemolytic Cytotoxic
50% Hemolysis | 58±23 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 2 Activity

Activity

50% Hemolysis
Toxicity
99±10 µM
Hemolytic Cytotoxic
50% Hemolysis | 99±10 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 3 Activity

Activity

50% Hemolysis
Toxicity
65±15 µM
Hemolytic Cytotoxic
50% Hemolysis | 65±15 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 4 Activity

Activity

50% Hemolysis
Toxicity
29±2.5 µM
Hemolytic Cytotoxic
50% Hemolysis | 29±2.5 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 5 Hemolysis

Source & Reference

HemoPI PD_Hemolysis
PD_Hemolysis